MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-14-0040989
Revenza Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.85 Cr
▲ 31% YoY
Net profit · FY 2024
₹11.83 Lakh
Net margin 3.1%
EBITDA · FY 2024
₹22.73 Lakh
EBITDA margin 5.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Employees · EPFO
32
Provident fund records
Directors on board
4
As per MCA filings
About Revenza Pharmaceuticals Private Limited
Data last updated:
Revenza Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2016PTC209990. Its GSTIN is 19AAHCR6898R1ZY (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Arindam Chakraborty (Whole-Time Director) and Sunil Samaddar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 38 Subhash Road Natagarh P.S. Ghola, Kolkata, West Bengal, India – 700113.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.85 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹11.83 Lakh (net margin 3.1%) and EBITDA of ₹22.73 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 25% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed by the company.
Revenza Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-14-0040989). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website revenzapharmaceuticals.in.
Company details
CIN U24100WB2016PTC209990
Registration Number 209990
Incorporation Date 26 February 2016
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-14-0040989
Key People
Arindam Chakraborty Whole-Time Director Sunil Samaddar Whole-Time Director Sudipta Ghosh Whole-Time Director Recognitions & Rankings of Revenza Pharmaceuticals
Contact details
Revenza Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its website is revenzapharmaceuticals.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address38 Subhash Road Natagarh P.S. Ghola, Kolkata, West Bengal, India – 700113
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Revenza Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Revenza Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Revenza Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Revenza Pharmaceuticals Private Limited, buy the company report.
Financials of Revenza Pharmaceuticals Private Limited
FY 2025 filings availableRevenza Pharmaceuticals Private Limited reported revenue of ₹3.85 Cr (up 31% YoY) for FY 2024.
Revenue · FY 2024
₹3.85 Cr ▲ 31%
Net profit · FY 2024
₹11.83 Lakh margin 3.1%
EBITDA · FY 2024
₹22.73 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 35%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 84%
5 years · compounded
▲ 48%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 31% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Revenza Pharmaceuticals Private Limited, buy the company report.
Board of directors of Revenza Pharmaceuticals Private Limited
Revenza Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arindam Chakraborty | Whole-Time Director | 26 Feb 2016 | 10 Years 8 Months | Current |
| Sunil Samaddar | Whole-Time Director | 26 Feb 2016 | 10 Years 8 Months | Current |
| Sudipta Ghosh Also directs: Nephro Immune Dialysis Medicine Private Limited | Whole-Time Director | 26 Feb 2016 | 10 Years 8 Months | Current |
| Abhijit Majumdar | Whole-Time Director | 26 Feb 2016 | 10 Years 8 Months | Current |
Auditor
Revenza Pharmaceuticals Private Limited is audited by KUMARROY BARMAN PRASANTA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMARROY BARMAN PRASANTA & ASSOCIATES | FY 2021 | 330634E |
Shareholding
The shareholding of Revenza Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Revenza Pharmaceuticals Private Limited, buy the company report.
Legal cases
Revenza Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Revenza Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, West Bengal | Writ petition | Filed by the company against State of West Bengal and Ors. | Disposed |
To see the full case history of Revenza Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revenza Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Revenza Pharmaceuticals Private Limited has a workforce of 32 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Employee count
32
Active EPFO establishments
1
Employee growth
-5.9%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 32 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Revenza Pharmaceuticals Private Limited, buy the company report.
GST
Revenza Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAHCR6898R1ZY | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Revenza Pharmaceuticals Private Limited, buy the company report.
Recent activity
Revenza Pharmaceuticals Private Limited has 8 board changes on record since 2016: 4 appointments and 4 cessations. The latest: Abhijit Majumdar ceased to be Director on 04 Sep 2017.
AGM
Revenza Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Revenza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Ceased
Abhijit Majumdar ceased to be Director.
Ceased
Arindam Chakraborty ceased to be Director.
Ceased
Sudipta Ghosh ceased to be Director.
Ceased
Sunil Samaddar ceased to be Director.
Appointed
Abhijit Majumdar was appointed as Whole-Time Director.
Appointed
Arindam Chakraborty was appointed as Whole-Time Director.
Appointed
Sudipta Ghosh was appointed as Whole-Time Director.
Appointed
Sunil Samaddar was appointed as Whole-Time Director.
Incorporation
26 Feb 2016
Revenza Pharmaceuticals Private Limited was registered on 26 Feb 2016 with Roc Kolkata Ii & aged 10 years 8 months as per MCA records.
Frequently asked questions
Revenza Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2016 (10+ years old) and is registered under CIN U24100WB2016PTC209990.
Revenza Pharmaceuticals has 4 current directors:
- Arindam Chakraborty - Whole-Time Director
- Sunil Samaddar - Whole-Time Director
- Sudipta Ghosh - Whole-Time Director
- Abhijit Majumdar - Whole-Time Director
The latest financial statements of Revenza Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Revenza Pharmaceuticals is 19AAHCR6898R1ZY, registered in West Bengal.
The CIN (Corporate Identification Number) of Revenza Pharmaceuticals is U24100WB2016PTC209990. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revenza Pharmaceuticals has 1 court case on record: 1 filed by the company.
Revenza Pharmaceuticals was incorporated on 26 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
Abhijit Majumdar ceased to be Director on 04 Sep 2017. Arindam Chakraborty ceased to be Director on 04 Sep 2017. Sudipta Ghosh ceased to be Director on 04 Sep 2017. Revenza Pharmaceuticals has 8 board changes on record in total.
Yes, Revenza Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-14-0040989).
Revenza Pharmaceuticals can be reached through the website revenzapharmaceuticals.in. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages